Home Top Movers AgeX Therapeutics Inc. (NYSE:AGE) stock surged in the premarket trading session; here’s...

AgeX Therapeutics Inc. (NYSE:AGE) stock surged in the premarket trading session; here’s why

In the premarket trading session, at last check AGE stock surged by 7.2% to $1.34. AGE stock closed previous session at $1.25 losing -3.85%. The AGE stock volume traded 80189.0 shares.  In the past year up-to-date AGE stock had jumped by 64.47% while in the past week the shares shed -6.02%

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

What is the business update on the AGE stock?

On 1st April 2021, the AgeX Therapeutics Inc. announced the business update and release of financial results of the fourth quarter 2020.

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

Read More

The company had recently entered into a supported sponsored collaboration with The Ohio State Universit. This coordination is focused on the utilization of AgeX-BAT1 in mice. This candidate is based on AgeX’s brown adipocyte tissue (BAT) cell treatment. The purpose of it is to decide if transplantation of AgeX-BAT1 cells may improve cardiovascular capacity, diet-incited obesity and metabolic wellbeing including glucose digestion.

AgeX has also partnered with a biopharmaceutical organization creating embryonic stem cell (ESC) derived mesenchymal stem cells (MSCs) known as ImStem Biotechnology Inc. The collaboration was based on non-exclusive sublicense that will contain royalties for the utilization of AgeX’s clinical-grade ESC line ESI-053 to determine ImStem’s investigational MSC item candidate IMS001 for improvement in COVID-19 as well as acute respiratory distress disorder (ARDS) from different causes. ImStem’s MSC item up-and-comer IMS001 is based on AgeX’s stem cell line ESI-053. In March 2020, IMS001 acquired FDA IND approval to start a human research in different sclerosis.

AgeX reported on March 12, 2021 the online distribution of research paper identifying with regeneration, maturing, and cancer in bioRxiv. The paper presents interesting information identifying with mechanisms that cells may use during the recovery period. The paper uncovers changes in specific qualities that may keep recovery from happening in aged people. It additionally gives proof that the group of qualities might be engaged with a wide exhibit of human tumors.

The company provides financial updates on AGE stock

The fourth quarter and full year result for the year 2020 has overall positively improved as compared to the year 2019. When we look at the highlights posted by the company we see that the company for the fourth quarter of 2020 reported Total Revenues of $0.5 million. While for the year ended December 31, 2020 the total revenues were $1.9 million, compared to $1.7 million in the same period in 2019. The company increased the Operating expenses by $2 million to $12.4 million in full year 2020 as compared to 2019. The net loss attributable for AGE stock equals $0.29 per share in 2020 compared to $0.33 per share for the period 2019.

About AgeX Therapeutics, Inc.

AgeX Therapeutics, Inc.,is a biotechnology company that specifically centers around the design, developmentand commercialization of novel therapeutics. These novel treatments areprimarily for human aging and degenerative illnesses. The organization was established in 2017 and is situated in Alameda,California.The company has its operations deployed in the market of United States. The organization’s lead cell-based helpful candidate being developed consists of AGEX-BAT1, a cell treatment product for the treatment of different age-related metabolic issues, for example, Type II adult on-set diabetes.AgeX Therapeutics, Inc. has a research coordinated effort with the University of California, Irvine on neural foundational cell research program for Huntington’s sickness and other neurological disorders; and Sernova Corp.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

The company also provides AGEX-VASC1, a cell-based treatment to reestablish vascular aid in ageing ischemic tissues, like the ischemic heart. Its lead drug-based investigative candidate is AGEX-iTR1547, for restoration of regenerative potential in a range of aged tissues affected by degenerative infections. Furthermore, the organization markets human embryonic stem cells; and GeneCards Database Suite, including genomic analysis calculations and analysis instruments for use by specialists at drug and biotechnology organizations, and different establishments.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

CureVac Inc. (CVAC) stock soar during pre-market trading. Here’s what you should know?

CureVac Inc. (NASDAQ: CVAC) stock declined by 38.99% at the last close while the CVAC stock price gains by 11.34% in the pre-market trading...

Why Iconix Brand Group Inc (ICON) stock turnaround in the after-hours on Thursday?

Iconix Brand Group Inc (ICON) shares started the Thursday, June 17, 2021, trading be losing 1.87% and close the normal trading session at $3.14...

ISun Inc. (ISUN) stock surged during current market trading. Here’s the update

ISun Inc. (NASDAQ: ISUN) stock gained by 19.51% in the current market trading. iSun, based in Burlington, Vermont, is a company built on ideals...

The Trade Desk Inc. (TTD) stock plunged during pre-market. Here’s to know why?

The Trade Desk Inc. (NASDAQ: TTD) stock gained by 0.76% at last close whereas the TTD stock price declines by 90.03% in the pre-market...

Synaptogenix Inc. (SNPX) stock soars during after-hour trading. Why so?

Synaptogenix Inc. (NASDAQ: SNPX) stock gained by 6.33% at last close while the SNPX stock price rises further by 13.48% in the after-hours trading...

CureVac Inc. (CVAC) stock soar during pre-market trading. Here’s what you should know?

CureVac Inc. (NASDAQ: CVAC) stock declined by 38.99% at the last close while the CVAC stock price gains by 11.34% in the pre-market trading...

Anpac Bio-Medical Science Inc. (ANPC) stock soars during pre-market trading. Here’s the update

Anpac Bio-Medical Science Inc. (NASDAQ: ANPC) stock gained by 0.46% at last close while the ANPC stock price surged by 22.40% in the pre-market...

VivoPower International Inc. (VVPR) stock soars during pre-market trading. What’s driving it high?

VivoPower International Inc. (NASDAQ: VVPR) stock gained by 1.13% at last close while the VVPR stock price surged during pre-market trading by 1.54%. VivoPower...

Related News

Edesa Biotech Inc. (EDSA) stock surged during current market trading. Here’s to know why?

Edesa Biotech Inc. (NASDAQ: EDSA) stock gained by 4.22% in the current market trading. Edesa Biotech is a clinical-stage biopharmaceutical business dedicated on the...

VivoPower International Inc. (VVPR) stock soars during pre-market trading. What’s driving it high?

VivoPower International Inc. (NASDAQ: VVPR) stock gained by 1.13% at last close while the VVPR stock price surged during pre-market trading by 1.54%. VivoPower...

Cleveland BioLabs Inc. (CBLI) stock surged during after-hour session. Here’s what’s happening?

Cleveland BioLabs Inc. (NASDAQ: CBLI) stock declined by 3.58% at the last close while the CBLI stock price gains by 17.53% during the after-hour...

Why Ares Commercial Real Estate Corp (ACRE) stock plummeted on Thursday?

Ares Commercial Real Estate Corporation (ACRE) shares slipped 4.35% in after-hours on Thursday, June 17, 2021, and close the trading at $15.60. Earlier, ACRE's...

Nano-X Imaging Ltd. (NNOX) stock gained in the current market trading. Here’s to know why?

Nano-X Imaging Ltd. (NASDAQ: NNOX) stock gained by 14.90% in the current market trading. Nanox which is an Israeli company started by serial entrepreneur...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam